Year To Quarter End Consolidated Statement Of Comprehensive Income

Carna Biosciences, Inc. - Filing #7722864

Concept 2018-01-01 to
2018-06-30
2017-01-01 to
2017-06-30
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-489,682,000 JPY
-316,142,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-497,000 JPY
72,000 JPY
Foreign currency translation adjustment
-967,000 JPY
-2,159,000 JPY
Other comprehensive income
-1,464,000 JPY
-2,087,000 JPY
Comprehensive income
-491,147,000 JPY
-318,229,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-491,147,000 JPY
-318,229,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.